Answers are grounded in this paper and cite their sources.
Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This "Focus on Molecular Imaging" article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging.
No takes yet. Share an insight, caveat, or question.
Mankoff et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: